[go: up one dir, main page]

BR9913991A - Métodos de sub-regulação da resposta imune a proteìnas terapêuticas - Google Patents

Métodos de sub-regulação da resposta imune a proteìnas terapêuticas

Info

Publication number
BR9913991A
BR9913991A BR9913991-0A BR9913991A BR9913991A BR 9913991 A BR9913991 A BR 9913991A BR 9913991 A BR9913991 A BR 9913991A BR 9913991 A BR9913991 A BR 9913991A
Authority
BR
Brazil
Prior art keywords
methods
therapeutic proteins
immune response
subregulation
agents
Prior art date
Application number
BR9913991-0A
Other languages
English (en)
Inventor
Jiahua Qian
Leon W Hoyer
Mary Collins
Gary S Gray
Original Assignee
Genetics Inst
American Nat Red Cross
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst, American Nat Red Cross filed Critical Genetics Inst
Publication of BR9913991A publication Critical patent/BR9913991A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Patente de Invenção: <B>"MéTODOS DE SUB-REGULAçãO DA RESPOSTA IMUNE A PROTEìNAS TERAPêUTICAS"<D>. Composições e métodos para o tratamento de um distúrbio hemostático usando-se agentes os quais promovem a hemostase e agentes os quais inibem um sinal co-estimulatório em uma célula T são proporcionados. As presentes composições e métodos possibilitam o tratamento de distúrbios hemostáticos usando-se proteínas terapêuticas estranhas, ao mesmo tempo em que submodula as respostas imunes às proteínas terapêuticas.
BR9913991-0A 1998-09-21 1999-09-21 Métodos de sub-regulação da resposta imune a proteìnas terapêuticas BR9913991A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15817898A 1998-09-21 1998-09-21
PCT/US1999/021991 WO2000016801A1 (en) 1998-09-21 1999-09-21 Methods of downmodulating the immune response to therapeutic proteins

Publications (1)

Publication Number Publication Date
BR9913991A true BR9913991A (pt) 2001-07-03

Family

ID=22566971

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9913991-0A BR9913991A (pt) 1998-09-21 1999-09-21 Métodos de sub-regulação da resposta imune a proteìnas terapêuticas

Country Status (21)

Country Link
EP (1) EP1115423A1 (pt)
JP (1) JP2002526455A (pt)
KR (1) KR20010085830A (pt)
CN (1) CN1331602A (pt)
AU (1) AU761206B2 (pt)
BR (1) BR9913991A (pt)
CA (1) CA2343916A1 (pt)
CZ (1) CZ20011021A3 (pt)
EA (1) EA005236B1 (pt)
HK (1) HK1039059A1 (pt)
HU (1) HUP0103960A3 (pt)
IL (1) IL142069A0 (pt)
LT (1) LT4920B (pt)
LV (1) LV12768B (pt)
MX (1) MXPA01002898A (pt)
NO (1) NO20011412L (pt)
NZ (1) NZ511034A (pt)
PL (1) PL346796A1 (pt)
SI (1) SI20626A (pt)
WO (1) WO2000016801A1 (pt)
ZA (1) ZA200103156B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397703A (en) 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
JP2003534291A (ja) * 2000-05-19 2003-11-18 ザ センター フォー ブラッド リサーチ インク Ｐ−セレクチン活性の変調による止血障害の診断及び治療方法
EP1636579A4 (en) * 2003-06-10 2011-10-05 Smiths Detection Inc SENSOR ASSEMBLY
GB201508024D0 (en) * 2015-05-11 2015-06-24 Haemostatix Ltd Haemostatic compositions

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171569A (en) 1985-03-15 1992-12-15 National Research Development Corporation Factor IX preparations uncontaminated by plasma components or pox virus
US4868112A (en) 1985-04-12 1989-09-19 Genetics Institute, Inc. Novel procoagulant proteins
US5422260A (en) 1986-05-29 1995-06-06 Genetics Institute, Inc. -Legal Affairs Human factor VIII:c muteins
US4994371A (en) 1987-08-28 1991-02-19 Davie Earl W DNA preparation of Christmas factor and use of DNA sequences
FR2657884B1 (fr) 1990-02-05 1994-09-02 Tm Innovation Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.
US5661008A (en) 1991-03-15 1997-08-26 Kabi Pharmacia Ab Recombinant human factor VIII derivatives
DE69226871T3 (de) 1991-06-27 2009-09-24 Bristol-Myers Squibb Co. CTL4A-Rezeptor, ihn enthaltenden Fusionsproteine und deren Verwendung
US5770197A (en) 1991-06-27 1998-06-23 Bristol-Myers Squibb Company Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules
WO1993009804A1 (en) 1991-11-18 1993-05-27 The Scripps Research Institute Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation
US5663060A (en) 1992-04-07 1997-09-02 Emory University Hybrid human/animal factor VIII
US5364771A (en) 1992-04-07 1994-11-15 Emory University Hybrid human/porcine factor VIII
US5744446A (en) 1992-04-07 1998-04-28 Emory University Hybrid human/animal factor VIII
US5621039A (en) 1993-06-08 1997-04-15 Hallahan; Terrence W. Factor IX- polymeric conjugates
JPH10504310A (ja) * 1994-08-19 1998-04-28 ノボ ノルディスク アクティーゼルスカブ 生物学的に活性な化合物で患者を治療する方法
JPH10507758A (ja) * 1994-10-19 1998-07-28 ジェネティック セラピー，インコーポレイテッド アデノウイルスおよび免疫抑制剤同時反復投与を伴う遺伝子治療
US5714583A (en) 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
DE69713499T3 (de) * 1996-03-20 2010-05-06 Bristol-Myers Squibb Co., Seattle Verfahren zur inhibierung der immunreaktion durch blockierung der gp39/cd40 und ctla4/cd28/b7 routen und zusammensetzung zu deren verwendung
EP0966302B1 (en) * 1997-01-10 2007-03-14 Biogen Idec MA Inc. Methods of therapeutic administration of anti-cd40l compounds
HUP0002048A3 (en) * 1997-06-20 2002-09-30 Biogen Idec Ma Inc Cambridge Cd154 blockade therapy for therapeutic protein inhibitor syndrome
US8112896B2 (en) 2009-11-06 2012-02-14 Hexagon Metrology Ab Articulated arm

Also Published As

Publication number Publication date
AU761206B2 (en) 2003-05-29
IL142069A0 (en) 2002-03-10
EA005236B1 (ru) 2004-12-30
NO20011412D0 (no) 2001-03-20
HK1039059A1 (zh) 2002-04-12
AU6057899A (en) 2000-04-10
HUP0103960A3 (en) 2003-09-29
KR20010085830A (ko) 2001-09-07
LV12768B (lv) 2002-06-20
PL346796A1 (en) 2002-02-25
NZ511034A (en) 2004-03-26
WO2000016801A9 (en) 2000-10-26
LT2001045A (en) 2002-01-25
CZ20011021A3 (cs) 2001-10-17
JP2002526455A (ja) 2002-08-20
LV12768A (en) 2001-12-20
LT4920B (lt) 2002-06-25
CA2343916A1 (en) 2000-03-30
EA200100385A1 (ru) 2001-10-22
NO20011412L (no) 2001-05-16
EP1115423A1 (en) 2001-07-18
HUP0103960A2 (hu) 2002-02-28
CN1331602A (zh) 2002-01-16
MXPA01002898A (es) 2002-06-04
WO2000016801A1 (en) 2000-03-30
SI20626A (sl) 2002-02-28
ZA200103156B (en) 2002-07-18

Similar Documents

Publication Publication Date Title
BR9807043A (pt) Mistura estabilizada que compreende fibrinogênio
BR9807577A (pt) Método para prevenir e retardar o inìcio da doença de alzheimer e sua composição
BR9914044A (pt) ésteres tetrahidropirido
BR9907189A (pt) Produtos da fração lipìdica do carotenóide de pepino do mar e métodos de uso
BR0206985A (pt) Anticorpos modificados e métodos de uso
BR9811260A (pt) Pequenas moléculas úteis no tratamento de doença inflamatória
DK0910647T3 (da) Human DNase i hyperaktive varianter
NO20010446L (no) Substituert anilidforbindelser og metoder
DK0865294T3 (da) Fremgangsmåder til reduktion eller bibeholdelse af reducerede niveauer afblodlipider under anvendelse af OB-proteinpræparater
BR9713338A (pt) Benzonaftiridinas como terapêuticos brÈnquicos.
BRPI0408466A (pt) composições farmacêuticas de inibidores de cetp e uso dos referidos inibidores
BR9713178A (pt) Inbidores espirocìclicos da metaloprotease.
DK0832081T3 (da) Bicykliske-aromatiske forbindelser
TR199802394A2 (xx) Proteinleri stabilize etmek i�in geli�tirilmi� proses.
BR9702074A (pt) Compostos biaril heterocíclicos composições farmacêuticas e cosméticas que os contêm e suas utilizações
BR9813514A (pt) Agente para tratamento de fibras queratìnicas
BR0013638A (pt) Novas moléculas semelhantes a interferon beta
FR2746098B1 (fr) Composes propynyl biaromatiques
BR0111158A (pt) Composto e sais fisiológicos do mesmo, método para tratar uma condição mediana por tnf-a em um paciente
BR9913991A (pt) Métodos de sub-regulação da resposta imune a proteìnas terapêuticas
WO2001017558A3 (en) Novel uses of mammalian ccr6 receptors and related reagents
ATE169618T1 (de) Piperidinylamide, sulfonamide und sulfoxamide als inhibitoren der cholesterin biosynthese
BR9811954A (pt) ácidos 3-aril-succinamido-hidroxâmicos, processos para sua produção e preparações farmacêuticas contendo estas substâncias
NO951762L (no) Stabilt preparat for behandling av blodkoagulasjonssykdommer, omfattende et aktivt koagulasjonsfremmende stoff
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання

Legal Events

Date Code Title Description
TC Change of name
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.